Viewing Study NCT03259867


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-01-02 @ 10:27 PM
Study NCT ID: NCT03259867
Status: RECRUITING
Last Update Posted: 2024-11-22
First Post: 2017-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of TATE and PD-1 Inhibitor in Liver Cancer
Sponsor: Teclison Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module